Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Newey

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Research Communications|November 22, 2023
Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγAlice Newey, Lu Yu, Louise J Barber, et al.
Frontiers in Immunology|September 8, 2025
Cell-targeted PD-1 agonists are potent NK-cell inhibitorsHarriet C Pope, Ana L Chiodetti, Alice Newey, et al.
Journal of the National Cancer Institute|April 24, 2020
Computational Image Analysis of T-Cell Infiltrates in Resectable Gastric Cancer: Association with Survival and Molecular SubtypesBenjamin R Challoner, Katharina von Loga, Andrew Woolston, et al.
Cancers|December 16, 2020
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and ChemotherapyFranciele H Knebel, Louise J Barber, Alice Newey, et al.
Journal for Immunotherapy of Cancer|November 19, 2019
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatmentAlice Newey, Beatrice Griffiths, Justine Michaux, et al.
Cancer Cell|July 10, 2019
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal CancerAndrew Woolston, Khurum Khan, Georgia Spain, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Research Communications|November 22, 2023
Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγAlice Newey, Lu Yu, Louise J Barber, et al.
Frontiers in Immunology|September 8, 2025
Cell-targeted PD-1 agonists are potent NK-cell inhibitorsHarriet C Pope, Ana L Chiodetti, Alice Newey, et al.
Journal of the National Cancer Institute|April 24, 2020
Computational Image Analysis of T-Cell Infiltrates in Resectable Gastric Cancer: Association with Survival and Molecular SubtypesBenjamin R Challoner, Katharina von Loga, Andrew Woolston, et al.
Cancers|December 16, 2020
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and ChemotherapyFranciele H Knebel, Louise J Barber, Alice Newey, et al.
Journal for Immunotherapy of Cancer|November 19, 2019
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatmentAlice Newey, Beatrice Griffiths, Justine Michaux, et al.
Cancer Cell|July 10, 2019
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal CancerAndrew Woolston, Khurum Khan, Georgia Spain, et al.
Pageof 1